"Tumor Protein p73" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A homolog of p53 TUMOR SUPPRESSOR PROTEIN that encodes full-length trans-activating and N-terminally-truncated (DeltaN) isoforms. Detection of splice variants and isoforms in the nervous system (human TELENCEPHALON, CHOROID PLEXUS; CEREBROSPINAL FLUID), embryonic tissue, human BREAST CANCER; OVARIAN CANCER, suggest roles in cellular differentiation.
|Tumor Protein p73
- Tumor Protein p73
- Protein p73, Tumor
- p73, Tumor Protein
- Protein p73
- p73, Protein
- p73 Protein
- Protein, p73
- Tumor Suppressor Protein p73
- Tap73 Protein, Human
- Human Tap73 Protein
- Protein, Human Tap73
Below are MeSH descriptors whose meaning is more general than "Tumor Protein p73".
Below are MeSH descriptors whose meaning is more specific than "Tumor Protein p73".
This graph shows the total number of publications written about "Tumor Protein p73" by people in this website by year, and whether "Tumor Protein p73" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
|Year||Major Topic||Minor Topic||Total|
To return to the timeline, click here.
Below are the most recent publications written about "Tumor Protein p73" by people in Profiles.
Lateral Thalamic Eminence: A Novel Origin for mGluR1/Lot Cells. Cereb Cortex. 2017 05 01; 27(5):2841-2856.
Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes. Oncogene. 2005 Jul 28; 24(32):5131-6.
Identification of the interleukin 4 receptor alpha gene as a direct target for p73. Cancer Res. 2003 Dec 01; 63(23):8145-52.
The p53 family member genes are involved in the Notch signal pathway. J Biol Chem. 2002 Jan 04; 277(1):719-24.
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage. Nature. 1999 Jun 24; 399(6738):814-7.
Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene. 1998 Dec 24; 17(25):3309-18.